CORPORATE STARATEGY


Global leader of Cell Therapy – “Cell A-to-Z”
We’d like to become a global leader in the Cell Therapy Industry leveraging with proprietary therapeutic cells and unique platform technologies
We’d like to become a global leader in the Cell Therapy Industry leveraging with proprietary therapeutic cells and unique platform technologies
A-to-Z Cells
- ES-derived MSSC
- iPS-derived MSSC
- Schwann Cells
- Muscle Cells
- Immune Cells
A-to-Z Platforms
- MSSC platform: original cells
- Direct conversion
- Chemical conversion
- RNA-based modification
- Automation